Seth J. Baum, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amgen Inc.(SIGNIFICANT), Regeneron(SIGNIFICANT), Novo Nordisk(SIGNIFICANT), Akcea(SIGNIFICANT), Sanofi-Aventis(MODEST), Madrigal(SIGNIFICANT) SPEAKER'S BUREAU: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Akcea(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT), Esperion(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Novartis Corporation(SIGNIFICANT), Akcea(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Regeneron(SIGNIFICANT), Sanofi-Aventis(MODEST), Axcella(SIGNIFICANT), Esperion(SIGNIFICANT), Altimmune(SIGNIFICANT)

View Full Disclosure